ArticleNeurotrauma reports2025
Accounting for Withdrawal of Life-Sustaining Treatment in the Analysis of Traumatic Brain Injury Studies.
Article in Neurotrauma reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Reporting practices and impact of withdrawal of life-sustaining treatment on outcomes in acute brain injury clinical trials: a literature review and simulation study.Critical care (London, England) · 2026Review
- Hospital mortality, withdrawal of life-sustaining therapy decisions and early secondary brain insults for critically ill traumatic brain injury patients in England, Wales and Northern Ireland (2009-2024): an observational cohort study.The Lancet regional health. Europe · 2026Article
- Disorders of consciousness diagnosis, interventions, and prognostication for the intensivist: Report of the 2025 ISICEM roundtable.Intensive care medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Studies that aim to evaluate outcomes after severe traumatic brain injury (TBI) must account for patients who die after withdrawal of life-sustaining treatment (WLST). If we are willing to assume that some of the patients who die of WLST might have had a good outcome at 6 months, the choice of analytic approach may impact the results. In this study, 6-month clinical outcomes for patients with TBI were simulated under six different scenarios related to WLST. Each scenario represents different assumptions related to the decision to choose WLST and how that decision relates to the 6-month clinical outcome. For each simulated dataset and scenario, three analytic approaches were used to estimate the probability of a good outcome at 6 months: complete case analysis, worst-case imputation, and inverse probability weighted analysis. The bias of the estimate from each of the approaches was used to compare the performance of the analysis approaches. When the probability of WLST was equal for all patients (i.e., covariates were not factored into the WLST decision), both the complete case analysis and the inverse probability weighted analysis were unbiased. When only patients who would have a poor outcome at 6 months were eligible to have WLST, only the worst-case imputation analysis was unbiased. When the probability of WLST was a function of observed patient characteristics that were also related to 6-month outcome (e.g., age, injury severity), only the inverse probability weighted analysis was unbiased. Finally, when the probability of missingness was related to an unobserved patient characteristic, none of the approaches were unbiased. If some patients who die of WLST might have had a good outcome, inverse probability weighting could be considered to decrease bias associated with censoring or imputing poor outcomes for participants with WLST.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.